date/time interval
- September 1, 2019 - August 31, 2021
New Covalent Antibody Anchoring Technology To Develop Novel Target Tunable, Multispecific Chemical Tumor Immunotherapeutics.
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 63129